Skip to main content

Table 3 Studied clinical parameters in patients reporting PNI symptoms and in patients without PNI symptoms

From: Incidence and risk factors of peripheral nerve injuries 3 months after ICU discharge: a retrospective study comparing COVID-19 and non-COVID-19 critically ill survivors

Variables

PNI group

(n = 31)

No PNI group

(n = 46)

p value

SAPS II

33 [27–40]

33 [24–40.5]

0.76

Mechanical ventilation, n (%)

24 (77.4)

28 (63.6)

0.18

Duration of mechanical ventilation, days

15 [6.5–29]

6 [0–15]

 < 0.01

Neuromuscular blocking duration, days

4 [3–5]

3 [2–5]

0.25

Prone position, n (%)

17 (60.7)

14 (37.8)

0.05

Corticosteroids, n (%)

17 (54.8)

26 (59.1)

0.71

Insulin infusion duration, days

11 [7–18]

14.5 [4.5–25]

0.71

CRP peak, mg/L

282 [219–353.3]

190.9 [127.3–309.1]

0.01

Glucose peak, mg/dL

220 [174–324]

230 [194.5–296]

0.82

ICU LOS, d

17 [12–35]

12 [8–21.5]

0.02

  1. CRP C-reactive protein, ICU intensive care unit, LOS length of stay, SAPS simplified acute physiology score